Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gehrlicher Pharmazeutische Extrakte GmbH is a specialized German manufacturer of high-quality herbal extracts for the pharmaceutical, cosmetic, and food industries. Founded in 1984 and headquartered in Eurasburg, the company produces a wide range of products including tinctures, fluid extracts, and dry extracts using state-of-the-art extraction technologies. Gehrlicher operates under strict GMP guidelines, ensuring the highest standards for active pharmaceutical ingredients (APIs) derived from botanical sources. The company's portfolio includes extracts from hundreds of different plants, tailored to specific customer requirements for potency and purity. In 2018, the company was acquired by the Martin Bauer Group, integrating its expertise into one of the world's leading botanical extract suppliers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gehrlicher Herbal Extracts.